Calamos Advisors LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2021$1,516,000
-67.5%
11,947
-71.9%
0.01%
-72.0%
Q1 2021$4,662,000
-48.7%
42,494
-33.2%
0.02%
-52.8%
Q4 2020$9,089,000
+136.3%
63,661
+16.8%
0.05%
+112.0%
Q3 2020$3,847,000
+2.7%
54,517
+1.9%
0.02%
-3.8%
Q2 2020$3,745,000
+207.7%
53,505
+53.7%
0.03%
+160.0%
Q1 2020$1,217,000
-64.2%
34,821
-35.7%
0.01%
-41.2%
Q4 2019$3,403,00054,1350.02%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders